Raising standards while watching the bottom line: making a business case for infection control. - Wikidata - awgldk - TriplyDB

Raising standards while watching the bottom line: making a business case for infection control.

Raising standards while watching the bottom line: making a business case for infection control.

http://www.wikidata.org/entity/Q36969302

about

Effectiveness and limitations of hand hygiene promotion on decreasing healthcare-associated infections Expanding roles of healthcare epidemiology and infection control in spite of limited resources and compensation.Hospital epidemiology and infection control in acute-care settings.Financial evaluations of antibiotic stewardship programs-a systematic review Economic burden of healthcare-associated infections: an American perspective.Clinical utility of infection control documentation of prior methicillin-resistant Staphylococcus aureus colonization or infection for optimization of empirical antibiotic therapy.Factors associated with variation in estimates of the cost of resistant infections Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs.Long-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia.Central line bundle implementation in US intensive care units and impact on bloodstream infections A research framework for reducing preventable patient harm Primary bacteraemia is associated with a higher mortality risk compared with pulmonary and intra-abdominal infections in patients with sepsis: a prospective observational cohort study.Infection control and prevention: a review of hospital-acquired infections and the economic implications.Impact of the ventilator bundle on ventilator-associated pneumonia in intensive care unit.Cost-Effectiveness of a National Initiative to Improve Hand Hygiene Compliance Using the Outcome of Healthcare Associated Staphylococcus aureus Bacteraemia.Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital.The Impact of Implementation of Bundle to Reduce Catheter-Related Bloodstream Infection Rates National Institute of Allergy and Infectious Disease (NIAID) Funding for Studies of Hospital-Associated Bacterial Pathogens: Are Funds Proportionate to Burden of Disease?Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.Sustaining clinical programs during difficult economic times: a case series from the Hospital Elder Life Program.Economics of infection control surveillance technology: cost-effective or just cost?Central Line-Associated Bloodstream Infection Reduction and Bundle Compliance in Intensive Care Units: A National Study.Optical fingerprinting in bacterial epidemiology: Raman spectroscopy as a real-time typing method.Estimating hospital costs of catheter-associated urinary tract infection Commentary: preventing Clostridium difficile-associated disease: is it time to pay the piper?Carbapenem Restriction and its Effect on Bacterial Resistance in an Intensive Care unit of a Teaching Hospital.Clinical and economic burden of antimicrobial resistance.Incidence rate and variable cost of nosocomial infections in different types of intensive care units.Successful implementation of a unit-based quality nurse to reduce central line-associated bloodstream infections.Barriers and facilitators to infection control at a hospital in northern India: a qualitative study Costs of hospital-acquired infection and transferability of the estimates: a systematic review.Antimicrobial stewardship in pediatric care: strategies and future directions.Antibiotic use in US hospitals: quantification, quality measures and stewardship.Bacterial distributions and prognosis of bloodstream infections in patients with liver cirrhosis.A Novel Prevention Bundle to Reduce Surgical Site Infections in Pediatric Spinal Fusion Patients.Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis.Anti-infective Acquisition Costs for a Stewardship Program: Getting to the Bottom Line.The sounds of silence: Public goods, externalities, and the value of infectious disease control programs.Healthcare infections associated with care and treatment of humans and animals.The business case for quality: economic analysis of the Michigan Keystone Patient Safety Program in ICUs.

P2860

Q28477999-FE5321D1-EEAB-44B5-91A3-E95813733E80 Q30227366-88EA5204-1BCD-44A4-9484-5E6BF70B2E5B Q30429049-39EF9494-E889-482C-99E0-225919A5AD33 Q30640528-82378476-EAC6-48A3-AF63-6F2014B9F3F5 Q33685288-15C6A5D8-4D8D-46F1-8F51-E64F513F3B41 Q33786482-9F20A52C-0491-4D60-BFDD-F58938253CF1 Q34077002-B8348421-DD28-4546-AEE6-822BC990EBEF Q34175419-D3EF014A-2811-45F4-91BE-77E530CEF1E3 Q34488701-9379ADBF-7206-4603-8C94-99A288C86126 Q34498641-7562895B-2BC8-4F78-BD46-3E2CCE7C0E1F Q34699187-0B311598-941F-4AD5-8110-5407915C2251 Q34903933-E30561A2-BFE7-4D1C-B891-FECA07EDBC07 Q34986301-AF580D55-BBA8-47A0-ABD4-A5519F3E6A4C Q35200100-60D55B27-4957-4658-85FF-7D29E26F4345 Q35918339-ED70144C-7405-4196-A1A3-283C1F6DFF15 Q35919643-1A076801-E64C-4BDA-855E-34711CC4F6EA Q36130624-F88D1376-87E9-4DD4-BEA3-15B2824A4598 Q36151660-526A0F4F-6082-42CD-B148-18C33762FB5A Q36379588-43BCB746-4B43-4D9A-98EF-F156A9107DE2 Q36657489-9959FF1F-A96F-4F4F-9D37-9F6B17E63209 Q36710983-D2DB1B70-6C71-45AC-BC21-6C42A12E46E4 Q37082282-5CB2CC2D-950B-4052-9A77-8E2555294559 Q37116744-FA0B7ACE-63A0-4F38-A1B9-02B1E2E110B0 Q37206276-1BE911AB-FB25-4AA6-8799-CDA27EDA6F1B Q37222664-CE0641E5-8222-4A40-B948-2872A123ABA5 Q37268544-AA4BFFBE-4E1A-4BE0-B983-B3216E77C32F Q37291374-34A81907-5440-4834-86D5-839271C5E9A6 Q37338202-FA44649F-2995-43FE-90DD-ED46245CFB49 Q37624731-579E7320-193A-4410-9B1E-BB25C0E4C89A Q37742337-550739A4-A503-4442-9759-BE61AFEE2E37 Q37855686-8D550FE5-28E8-490C-96C1-D7D4DC46C4F0 Q38073199-7CBE0DAF-0A1B-4E6F-A3B9-6A972A0C3766 Q38449948-B82220B8-2D94-42CD-967B-1BF88BA6E878 Q40047816-7B5BA977-DC1E-450A-B350-62F9D2677C44 Q40815294-829C8663-4D7C-40EE-8BE0-EBD403A3FE30 Q41075995-860B7C3A-C3DA-49B8-957C-66C70D526F7A Q41987292-B9A959C3-1458-4DC8-9A93-A3D0D724347C Q43100440-819D2DB2-C63C-4F06-BA63-EA500ECDE306 Q43189069-40C8DDE2-7447-4634-866D-112089027B6F Q43651821-3C06EF94-C74A-443F-9D5A-B1DC611C6F3D

P2860

Raising standards while watching the bottom line: making a business case for infection control.

http://www.wikidata.org/entity/Q36969302

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Raising standards while watchi ...... ss case for infection control.

@en

type

label

Raising standards while watchi ...... ss case for infection control.

@en

prefLabel

Raising standards while watchi ...... ss case for infection control.

@en

P1433

Q36969302-6687F205-CE7E-4CF7-8C1C-104FEB4C2FA8

P1476

Q36969302-D7492D94-47C7-4C28-B72D-4D75D5E20710

P2093

Q36969302-6138911F-65DB-415A-BECC-2657E290FABF

Q36969302-A7CC0C3A-70A8-4FE6-9834-8EDF6382B4C2

Q36969302-D4079C26-24C6-45FF-964D-1302FF4289E5

Q36969302-DD9E45D3-E6B7-406B-A67E-159FF2CF9BB6

Q36969302-F79EBB6D-F716-4774-9695-A1B2BEAE17C5

P2860

Q36969302-0A1FBDF8-B0D9-4D23-A765-2C5EC11FF53B

Q36969302-0AC5EF8B-7E07-4F2B-B90E-F410D01DAA94

Q36969302-1A028970-81D2-4019-9015-CBFE53CB0CD1

Q36969302-1D426ED1-6AD6-45FE-9FAE-0167A66B3FF7

Q36969302-28FF2B03-B2AF-4D9C-A9BE-EA9A59A248C6

Q36969302-2A69023D-ABE5-4A4A-B507-1CC64FAC7064

Q36969302-2C57BCE9-0D95-4423-B9DB-9143675F9508

Q36969302-2CA13E88-F873-4C2D-8259-FA449599F61A

Q36969302-2E8EEAA0-8A43-4FA2-9A3C-3C8079CABD91

Q36969302-2F8D9189-E240-4D8B-9862-5EE4221F322A

P304

Q36969302-92BFE672-EE27-40AC-AB45-C94C27F63929

P31

Q36969302-184A62CB-17A9-4C46-9E3C-9FB78ED91A44

P356

Q36969302-B073BABD-D84B-4CA8-B4ED-2B686A491089

P433

Q36969302-C0C9FDC1-4633-4DFC-9F02-C9EAEBB2D640

P478

Q36969302-7781BCD8-69B7-42DE-9B44-721F4ACC2173

P50

Q36969302-1FA8CBD1-3816-40C5-BCA6-F625F1D2CC99

Q36969302-7B82D6F5-B9D4-4ECD-91B6-29BA96EFA792

P577

Q36969302-E167A012-56B1-44C4-9BBE-868EAD0B2EA2

P5875

Q36969302-4E9581D9-8C6B-451E-9F8A-C77C10E007BE

P698

Q36969302-361F4D2D-F5E9-4EAA-B387-E4A920C467A3

P356

P1433

Infection Control and Hospital Epidemiology

P1476

Raising standards while watchi ...... ss case for infection control.

@en

P2093

David N Fisman

http://www.w3.org/2001/XMLSchema#string

Patricia W Stone

http://www.w3.org/2001/XMLSchema#string

Sara E Cosgrove

http://www.w3.org/2001/XMLSchema#string

Sharon B Wright

http://www.w3.org/2001/XMLSchema#string

Yehuda Carmeli

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in published cost effectiveness studies: systematic review.

Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing.

Transmission dynamics and control of severe acute respiratory syndrome

Randomized, controlled trials, observational studies, and the hierarchy of research designs

Public reporting and pay for performance in hospital quality improvement

Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

APACHE II: a severity of disease classification system

Infection control and cost control in the era of managed care.

Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.

P304

1121-1133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/521852

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Society for Healthcare Epidemiology of America

Eli Perencevich

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5912312

http://www.w3.org/2001/XMLSchema#string

P698

17933084

http://www.w3.org/2001/XMLSchema#string